These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 25528765)
21. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. Agajanian M; Runa F; Kelber JA Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948 [TBL] [Abstract][Full Text] [Related]
22. Loss of Git2 induces epithelial-mesenchymal transition by miR146a-Cnot6L-controlled expression of Zeb1. Zhou W; Thiery JP J Cell Sci; 2013 Jun; 126(Pt 12):2740-6. PubMed ID: 23591815 [TBL] [Abstract][Full Text] [Related]
23. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Tryndyak VP; Beland FA; Pogribny IP Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049 [TBL] [Abstract][Full Text] [Related]
24. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070 [TBL] [Abstract][Full Text] [Related]
25. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism. Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802 [TBL] [Abstract][Full Text] [Related]
26. TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Zhang J; Tian XJ; Zhang H; Teng Y; Li R; Bai F; Elankumaran S; Xing J Sci Signal; 2014 Sep; 7(345):ra91. PubMed ID: 25270257 [TBL] [Abstract][Full Text] [Related]
27. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells. Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256 [TBL] [Abstract][Full Text] [Related]
28. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803 [TBL] [Abstract][Full Text] [Related]
29. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238 [TBL] [Abstract][Full Text] [Related]
30. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Zhang P; Wei Y; Wang L; Debeb BG; Yuan Y; Zhang J; Yuan J; Wang M; Chen D; Sun Y; Woodward WA; Liu Y; Dean DC; Liang H; Hu Y; Ang KK; Hung MC; Chen J; Ma L Nat Cell Biol; 2014 Sep; 16(9):864-75. PubMed ID: 25086746 [TBL] [Abstract][Full Text] [Related]
31. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Chu K; Boley KM; Moraes R; Barsky SH; Robertson FM Oncotarget; 2013 Mar; 4(3):446-62. PubMed ID: 23530113 [TBL] [Abstract][Full Text] [Related]
32. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Lehmann W; Mossmann D; Kleemann J; Mock K; Meisinger C; Brummer T; Herr R; Brabletz S; Stemmler MP; Brabletz T Nat Commun; 2016 Feb; 7():10498. PubMed ID: 26876920 [TBL] [Abstract][Full Text] [Related]
33. HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma. Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L J Exp Clin Cancer Res; 2015 Oct; 34():133. PubMed ID: 26514226 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation. Meng X; Kong DH; Li N; Zong ZH; Liu BQ; Du ZX; Guan Y; Cao L; Wang HQ Cell Death Dis; 2014 Feb; 5(2):e1092. PubMed ID: 24577090 [TBL] [Abstract][Full Text] [Related]
35. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer. Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049 [TBL] [Abstract][Full Text] [Related]
36. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496 [TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line. Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606 [TBL] [Abstract][Full Text] [Related]